Saudi - Delayed Quote SAR

Saudi Pharmaceutical Industries and Medical Appliances Corporation (2070.SR)

36.95 -0.80 (-2.12%)
As of 12:35 PM GMT+3. Market Open.
Key Events
Loading Chart for 2070.SR
DELL
  • Previous Close 37.75
  • Open 37.50
  • Bid 36.95 x --
  • Ask 37.00 x --
  • Day's Range 36.95 - 38.00
  • 52 Week Range 24.86 - 45.25
  • Volume 146,856
  • Avg. Volume 1,092,491
  • Market Cap (intraday) 4.425B
  • Beta (5Y Monthly) 0.61
  • PE Ratio (TTM) --
  • EPS (TTM) -0.16
  • Earnings Date May 13, 2024 - May 16, 2024
  • Forward Dividend & Yield --
  • Ex-Dividend Date Jun 9, 2022
  • 1y Target Est 38.00

Saudi Pharmaceutical Industries and Medical Appliances Corporation develops, manufactures, and markets medicinal and pharmaceutical products in the Kingdom of Saudi Arabia. The company is also involved in the manufacturing of basic chemical substances and products; medicines for human use, including cosmetics, as well as engages in wholesale and retail of medicines and related products. It operates and maintains healthcare facilities. In addition, the company engages in the research and development of medical science activities. The company was founded in 1986 and is based in Buraydah, the Kingdom of Saudi Arabia.

www.spimaco.com.sa

--

Full Time Employees

December 31

Fiscal Year Ends

Related News

Performance Overview: 2070.SR

Trailing total returns as of 4/28/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

2070.SR
1.99%
Tadawul All Shares Index
2.48%

1-Year Return

2070.SR
44.34%
Tadawul All Shares Index
8.49%

3-Year Return

2070.SR
12.09%
Tadawul All Shares Index
19.10%

5-Year Return

2070.SR
41.55%
Tadawul All Shares Index
31.83%

Compare To: 2070.SR

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: 2070.SR

Valuation Measures

Annual
As of 4/25/2024
  • Market Cap

    4.52B

  • Enterprise Value

    5.36B

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    2.74

  • Price/Book (mrq)

    3.00

  • Enterprise Value/Revenue

    3.24

  • Enterprise Value/EBITDA

    30.83

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -0.83%

  • Return on Assets (ttm)

    1.54%

  • Return on Equity (ttm)

    -0.54%

  • Revenue (ttm)

    1.65B

  • Net Income Avi to Common (ttm)

    -20.2M

  • Diluted EPS (ttm)

    -0.16

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    276.02M

  • Total Debt/Equity (mrq)

    67.10%

  • Levered Free Cash Flow (ttm)

    -13.25M

Research Analysis: 2070.SR

Analyst Price Targets

34.00 Low
38.00 Average
36.95 Current
45.00 High
 

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell
 

Company Insights: 2070.SR

People Also Watch